As of June 30, 2026, ASYMCHEM LABORATORIES TIANJIN CO LTD. carries a market capitalization of 7.11B, placing it among publicly traded companies globally. Its enterprise value stands at 6.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.11B |
| Enterprise Value | 6.20B |
ASYMCHEM LABORATORIES TIANJIN CO LTD.'s next confirmed earnings release is scheduled for April 1, 2027.
| Earnings Date | 4/1/2027 |
As of June 30, 2026, ASYMCHEM LABORATORIES TIANJIN CO LTD. has 1.12B shares outstanding.
| Shares Outstanding | 1.12B |
These figures are as of June 30, 2026.
| PB Ratio | 2.72 |
| P/TBV Ratio | 2.82 |
As of June 30, 2026, ASYMCHEM LABORATORIES TIANJIN CO LTD. maintains a current ratio of 4.56, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.56 |
| Quick Ratio | 2.76 |
| Debt / Equity | 1.95 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 10,361.50 |
Over the twelve months ended June 30, 2026, ASYMCHEM LABORATORIES TIANJIN CO LTD. recorded 16.91M in income tax expense.
| Income Tax | 16.91M |
As of the close on August 7, 2026, ASYMCHEM LABORATORIES TIANJIN CO LTD.'s stock has gained approximately 154.69% over the past 52 weeks.
| 52-Week Price Change | 154.69% |
As of June 30, 2026, ASYMCHEM LABORATORIES TIANJIN CO LTD. holds 969.07M in cash and equivalents against 51.09M in total debt, resulting in a net debt position of -808.12M. Total book value stands at 2.61B, with working capital of 1.25B providing operational flexibility.
| Cash & Cash Equivalents | 969.07M |
| Total Debt | 51.09M |
| Net Debt | -808.12M |
| Equity (Book Value) | 2.61B |
| Book Value Per Share | 2.34 |
| Working Capital | 1.25B |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -189.74M |
Already premium?